Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovaBay Pharmaceuticals

0.5702
-0.0070-1.21%
Volume:10.86K
Turnover:6.31K
Market Cap:3.32M
PE:-0.22
High:0.6000
Open:0.5800
Low:0.5701
Close:0.5772
Loading ...

BRIEF-Novabay Pharmaceuticals Engages Financial Advisor Should Stockholders Fail To Approve Dissolution Proposal

Reuters
·
07 Mar

NovaBay Pharmaceuticals Inc: Stockholders as of March 18, 2025 Record Date Will Be Entitled to Vote

THOMSON REUTERS
·
07 Mar

NovaBay Pharmaceuticals Inc: Engages Financial Advisor to Explore Strategic Options Should Stockholders Fail to Approve Dissolution Proposal

THOMSON REUTERS
·
07 Mar

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Business Wire
·
07 Mar

BRIEF-Novabay Pharmaceuticals Completes The Sale Of Its Eyecare Business To Prn

Reuters
·
23 Jan

NovaBay Pharmaceuticals Completes the Sale of Its Eyecare Business to Prn and Further Adjourns Its Special Meeting of Stockholders on Dissolution Proposal

THOMSON REUTERS
·
23 Jan

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Business Wire
·
23 Jan

NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why

Zacks
·
26 Dec 2024

ISS supports NovaBay proposals to sell Avenova business

TIPRANKS
·
15 Nov 2024

BRIEF-NovaBay Pharmaceuticals ISS Supports Co's Proposals To Authorize Sale Of Its Avenova Brand

Reuters
·
15 Nov 2024

NovaBay Pharmaceuticals: Iss Supports Co's Proposals to Authorize Sale of Its Avenova Brand

THOMSON REUTERS
·
15 Nov 2024

NovaBay Pharmaceuticals Reports Q3 2024 Financials Amid Strategic Changes

TIPRANKS
·
15 Nov 2024

NovaBay Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
12 Nov 2024

NovaBay Pharmaceuticals Q3 EPS $(0.60) Misses $(0.30) Estimate, Sales $2.44M Miss $2.62M Estimate

Benzinga
·
08 Nov 2024

NovaBay Pharmaceuticals Inc: Qtrly Shr Loss $0.60

THOMSON REUTERS
·
08 Nov 2024

BRIEF-Novabay Pharmaceuticals accepts revised offer from Nutriceuticals

Reuters
·
07 Nov 2024

NovaBay accepts revised transaction proposal from PRN

TIPRANKS
·
07 Nov 2024

NovaBay Pharmaceuticals: Accepts Revised Offer From Nutriceuticals, Enters Into Amendment to Asset Purchase Agreement to Increase Purchase Price

THOMSON REUTERS
·
07 Nov 2024

BRIEF-NovaBay Pharmaceuticals Board Determines Unsolicited Offer Is Superior To Asset Purchase Agreement With PRN Physician Recommended Nutriceuticals, LLC

Reuters
·
29 Oct 2024

NovaBay Pharmaceuticals: Refresh's Offer Also Includes Refresh Providing a Secured Term Loan to Co in Principal Amount of $2.0 Mln

THOMSON REUTERS
·
29 Oct 2024